AU2003248679A8 - Treating disease using radium-225 - Google Patents

Treating disease using radium-225

Info

Publication number
AU2003248679A8
AU2003248679A8 AU2003248679A AU2003248679A AU2003248679A8 AU 2003248679 A8 AU2003248679 A8 AU 2003248679A8 AU 2003248679 A AU2003248679 A AU 2003248679A AU 2003248679 A AU2003248679 A AU 2003248679A AU 2003248679 A8 AU2003248679 A8 AU 2003248679A8
Authority
AU
Australia
Prior art keywords
radium
treating disease
disease
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003248679A
Other versions
AU2003248679A1 (en
Inventor
Kenneth R Givens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actinium Pharmaceuticals Ltd
Original Assignee
Actinium Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actinium Pharmaceuticals Ltd filed Critical Actinium Pharmaceuticals Ltd
Publication of AU2003248679A8 publication Critical patent/AU2003248679A8/en
Publication of AU2003248679A1 publication Critical patent/AU2003248679A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
AU2003248679A 2002-06-14 2003-06-12 Treating disease using radium-225 Abandoned AU2003248679A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38880802P 2002-06-14 2002-06-14
US60/388,808 2002-06-14
PCT/US2003/018634 WO2003105762A2 (en) 2002-06-14 2003-06-12 Treating disease using radium-225

Publications (2)

Publication Number Publication Date
AU2003248679A8 true AU2003248679A8 (en) 2003-12-31
AU2003248679A1 AU2003248679A1 (en) 2003-12-31

Family

ID=29736547

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003248679A Abandoned AU2003248679A1 (en) 2002-06-14 2003-06-12 Treating disease using radium-225

Country Status (2)

Country Link
AU (1) AU2003248679A1 (en)
WO (1) WO2003105762A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1763372B1 (en) 2004-06-25 2016-11-30 The European Union, represented by the European Commission Radionuclides for medical use
EP3316871A4 (en) 2015-06-30 2019-02-20 The Trustees of Columbia University in the City of New York Talc-bound compositions and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX174467B (en) * 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-TRISCARBOXIMETHYL-1,4,7,10-TETRAAZACICLODO DECAN SUBSTITUTE IN 1 AND ANALOG COMPOUNDS
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
GB9203037D0 (en) * 1992-02-11 1992-03-25 Salutar Inc Contrast agents
WO1994026297A1 (en) * 1993-05-17 1994-11-24 Immunomedics, Inc. Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
US5961955A (en) * 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
US6296831B1 (en) * 1998-04-10 2001-10-02 Battelle Memorial Institute Stimulus sensitive gel with radioisotope and methods of making

Also Published As

Publication number Publication date
WO2003105762A3 (en) 2004-03-04
AU2003248679A1 (en) 2003-12-31
WO2003105762A2 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
EP1689485A4 (en) Cardioelectromagnetic treatment
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
GB0326486D0 (en) Combination treatment
GB0312407D0 (en) Treatment
HK1078784A1 (en) Therapeutic treatment
GB0223367D0 (en) Therapeutic treatment
GB0223570D0 (en) Surface treatment
GB2388557B (en) Treatment system
AU2003298719A8 (en) Treatment for sma disease
AU2003223780A8 (en) Treatment for pompe disease
GB0221574D0 (en) Treatments
GB0210464D0 (en) Therapeutic treatment
GB0221157D0 (en) Novel treatment
GB2385333B (en) Plate treatment
AU2003248679A8 (en) Treating disease using radium-225
GB0128628D0 (en) Disease treatment
AU2003231937A8 (en) Therapeutic methods
GB0211297D0 (en) Pain treatment
AU2003292367A8 (en) Soil treatment
GB2383538B (en) Cancer treatment
GB0212821D0 (en) Eyewash
GB0220820D0 (en) Treatment
GB0213493D0 (en) Treatment
GB0213383D0 (en) Therapeutic conditions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase